Latest Convertible Notes News

Page 5 of 91
Cassius Mining ended the September quarter with A$1.159 million in cash, equivalent to 0.35 quarters of funding at its reported current outgoings. The company is advancing environmental and social studies at its large Madagascar limestone project while awaiting a final Ghana arbitration award and seeking additional funding or a development partner.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Duxton Farms returned to positive operating cash flow in the September quarter, but its balance sheet remains stretched with a $13.98 million net overdraft and $103.25 million of drawn financing. A secured convertible note raise and a delayed asset sale are now central to the company’s funding position.
Ada Torres
Ada Torres
30 Oct 2026
HITIQ has expanded its military research ambitions and added fresh funding during the September quarter, but the company ended the period with $658,242 in cash and estimated funding for only one quarter. Its US collaboration remains non-binding, leaving financing and commercial execution as the immediate tests.
Victor Sage
Victor Sage
30 Oct 2026
Nutritional Growth Solutions has cut quarterly net operating cash outflow by 54% while completing its Sprout Organic acquisition just after quarter end. The enlarged group starts with US$1.613 million in cash, no borrowings and a substantially larger share base.
Victor Sage
Victor Sage
30 Oct 2026
Native Mineral Resources’ first full year as a gold producer delivered A$24.1 million in revenue and a late-year production surge, but the balance sheet remains under acute pressure. The ASX-listed miner reported a A$34.8 million loss, negative operating cash flow and a material uncertainty over its ability to continue as a going concern.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Novatti’s AU/NZ quarterly transaction value rose to $1.2 billion, but regulatory disruption to international BPAY payments pushed revenue lower and left Cash EBITDA negative. The company is targeting an early 2027 relaunch while relying on pipeline conversion and product mix improvements to support its next phase of growth.
Claire Turing
Claire Turing
30 Oct 2026
Northern Minerals has advanced Browns Range through feasibility, engineering and exploration, but its flagship rare earths project remains stalled at the funding gate. The company missed its 30 September FID target, flagged material uncertainty over its ability to continue as a going concern and warned that Iluka may be able to terminate the project’s supply agreement.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Papyrus Australia says its second production-scale board run delivered significantly improved internal test results, with samples now sent to TBS for acceptance testing. The progress is tempered by a reported $365,000 cash balance, $447,000 in unused facilities and estimated funding for just 1.51 quarters.
Victor Sage
Victor Sage
30 Oct 2026
Sprintex has moved its €25.71 million Mest Water order book into commercial manufacturing after receiving A$1.3 million in customer payments. The progress comes alongside a sharply constrained funding position, with A$166,000 in cash and estimated funding of just 0.17 quarters at September-end.
Victor Sage
Victor Sage
29 Oct 2026
Chimeric Therapeutics has stopped enrolment and dosing in its CHM-2101 CAR-T trial after a safety review found the highest dose unsafe. With $1.35 million in cash, suspended securities and uncertain creditor negotiations, the company is now pursuing a possible recapitalisation while preserving a preclinical CDH17 pathway.
Ada Torres
Ada Torres
29 Oct 2026
Beonic has launched its in-house Vision platform across four countries while delivering a profitable first quarter, with EBITDA of A$853,000 and an 83.0% gross margin. The stronger operating result came alongside weaker total revenue, negative operating cash flow and only 1.7 quarters of estimated funding.
Sophie Babbage
Sophie Babbage
29 Oct 2026
Mindax ended FY2026 with just A$83,116 in cash and a A$2.49 million loss before tax, prompting its auditor to highlight material uncertainty over the company’s ability to continue as a going concern. Post-year-end funding has lifted cash to A$4.079 million, although much of that support remains tied to convertible debt and approvals.
Maxwell Dee
Maxwell Dee
29 Oct 2026

Browse the archive

Full archive